Bempedoic acid alone lowers CVD risk in statin-intolerant adults: study
By
Alicia Lasek
Mar 07, 2023
In a first, the non-statin, cholesterol-lowering drug bempedoic acid (Nexletol) has been found to lower the risk of adverse cardiovascular events and death in statin-intolerant patients.
Statin initiation linked to greater progression of diabetes
Oct 04, 2021
Each individual component of the composite outcome was significantly higher among statin users
Statin use is linked to fewer foot infections in new study
By
Kimberly Marselas
Jun 05, 2017
Prior therapy with atorvastatin considerably reduces the onset of diabetic foot infections and may be useful in preventing them, according to Iranian researchers.
Side benefit of statin drug includes lower infection rates
Sep 07, 2011
Some people must be asking themselves: Is there nothing statins can’t do? New research suggests that atorvastin (Lipitor) is not only successful at reducing the risk of coronary heart disease and...